Abstract

BackgroundClinical outcome measurement in multiple sclerosis (MS) usually requires a physical visit. Remote activity monitoring (RAM) using wearable technology provides a rational alternative, especially desirable when distance is involved or in a pandemic setting.ObjectiveTo validate RAM in progressive MS using (1) traditional psychometric methods (2) brain atrophy.Methods56 people with progressive MS participated in a longitudinal study over 2.5 years. An arm-worn RAM device measured activity over six days, every six months, and incorporated triaxial accelerometry and transcutaneous physiological variable measurement. Five RAM variables were assessed: physical activity duration, step count, active energy expenditure, metabolic equivalents and a composite RAM score incorporating all four variables. Other assessments every six months included EDSS, MSFC, MSIS-29, Chalder Fatigue Scale and Beck’s Depression Inventory. Annualized brain atrophy was measured using SIENA.ResultsRAM was tolerated well by people with MS; the device was worn 99.4% of the time. RAM had good convergent and divergent validity and was responsive, especially with respect to step count. Measurement of physical activity over one day was as responsive as six days. The composite RAM score positively correlated with brain volume loss.ConclusionRemote activity monitoring is a valid and acceptable outcome measure in MS.

Highlights

  • Monitoring progression in Multiple Sclerosis (MS) is essential for clinical management and research

  • Remote disease monitoring is becoming increasingly desirable to reduce trips to hospitals for patientspecific, public health and environmental reasons, and the availability of patient outcome measures during remote neurology consultations would improve the quality of teleneurology.[4,28,29]

  • While questionnaires can be utilised for remote disease monitoring, Remote activity monitoring (RAM) was more responsive than the three questionnaires assessed here (MSIS-29, Chalder Fatigue Scale and BDI)

Read more

Summary

Introduction

Monitoring progression in Multiple Sclerosis (MS) is essential for clinical management and research. Sclerosis Functional Composite (MSFC) is increasingly being used as an outcome measure in MS studies; it provides an improved clinical measure of disability by combining ambulation (the timed 25-foot walk, T25FW), upper limb function (a timed 9-hole peg test, 9HPT) and cognitive function (the Paced Auditory Serial Addition Test, PASAT).[3]. Clinic-based tests such as the EDSS and MSFC provide a single snapshot of disability at one point in time and in an artificial environment. Clinical outcome measurement in multiple sclerosis (MS) usually requires a physical visit. Objective: To validate RAM in progressive MS using (1) traditional psychometric methods (2) brain atrophy. Conclusion: Remote activity monitoring is a valid and acceptable outcome measure in MS

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call